Optidel Biosystems

optidelbiosystems.com ↗ ·Zamudio ·Seed

Optidel Biosystems is a Basque deep-tech biotechnology company founded in 2023 as a spin-off of the GAIKER Technology Centre (BRTA), based at the Bizkaia Science and Technology Park in Zamudio. It has a patented delivery/solubilisation platform that turns poorly soluble natural actives — polyphenols such as ferulic acid, quercetin, luteolin or mangostin — into stable, clear, high-bioavailability ingredients for aqueous systems, and sells both custom cosmetic ingredients/formulations and technology licences to cosmetics, dermatology, pharma and functional-food companies. It was incorporated by institutional shareholders (Fundación GAIKER ~60% and Sistemas de Biotecnología y Recursos Naturales S.L. ~40%) under the Basque Tek Ventures venture-builder programme, and has 2-10 employees.

Founded

2023

Founders

Total funds raised

—

SectorsBiotechnology, Cosmetics & Personal Care, Deep Tech, Ingredients, Functional Food Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Oihane Vesga

CEO & Technical Director

Global models 5

Modern Meadow

United States · www.modernmeadow.com ↗

Biotech platform company that sells proprietary bio-based ingredients (Bio-VERA) to beauty and materials brands and licenses its technology, the same mix of ingredients plus licensing as Optidel.

$186MComparable

Evolved By Nature

United States · evolvedbynature.com ↗

Turns a natural material (silk protein) into patented functional ingredients that it supplies and licenses to cosmetics, skincare and textile companies, much like Optidel's natural-active platform.

$150MComparable

Geltor

United States · geltor.com ↗

B2B supplier of biodesigned collagen and protein ingredients to cosmetics, nutrition and food brands, a platform-to-ingredient business model like Optidel's.

$114MComparable

Nuritas

Ireland · www.nuritas.com ↗

Discovers and develops natural bioactive peptide ingredients, then sells and licenses them to food, supplement and cosmetics partners, which mirrors Optidel's model of natural actives sold as ingredients and licences.

$75MComparable

Nanoform

Finland · nanoform.com ↗

Patented particle-engineering platform that improves the solubility and bioavailability of poorly soluble molecules, sold to pharma partners as services and licences, the closest technical match to Optidel's solubilisation platform.

$40MComparable

In the same niche 26 others

See all in the Start-ups Map →

No stage disclosed · €4.2M

+20 more →

Notes: Most funded first

Investors 3

Open as list →

SPRI

www.spri.eus/en/support/basque-tek-ventures

Seed 2025 Spain

BasketekVenture

Led Seed 2025 Spain

Fundación GAIKER

www.gaiker.es ↗

Investor Spain

Funding rounds 1

Date	Round	Amount	Lead
2025-03-27	Seed (estimated)	—	BasketekVenture +1 more

News 2

Open as list →

Published	Article
2025-03-27	Optidel Biosystems receives backing from venture capital investors ↗ GAIKER (press release) 2025-03-27
2024-05-10	OPTIDEL Biosystems: low liquefiable polyphenol solubilisation ↗ SPRI Group 2024-05-10